JPMORGAN CHASE & CO - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 44 filers reported holding CLEARSIDE BIOMEDICAL INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$2,768
-39.4%
3,182
-22.0%
0.00%
Q2 2023$4,566
+52.2%
4,077
+30.7%
0.00%
Q1 2023$3,000
+19900.0%
3,119
-77.5%
0.00%
Q4 2022$15
-99.9%
13,874
+24.6%
0.00%
Q3 2022$12,000
-55.6%
11,138
-38.7%
0.00%
Q2 2022$27,000
+28.6%
18,161
+100.6%
0.00%
Q1 2022$21,000
+5.0%
9,052
+24.7%
0.00%
Q4 2021$20,000
+66.7%
7,260
+263.0%
0.00%
Q3 2021$12,000
-67.6%
2,000
-73.3%
0.00%
Q2 2021$37,000
+208.3%
7,500
+50.0%
0.00%
Q1 2021$12,000
+71.4%
5,000
+100.0%
0.00%
Q4 2020$7,000
-30.0%
2,500
-61.5%
0.00%
Q3 2020$10,000
+11.1%
6,500
+30.0%
0.00%
Q2 2020$9,0000.0%5,0000.0%0.00%
Q1 2020$9,000
-88.0%
5,000
-80.8%
0.00%
Q4 2019$75,000
+1150.0%
26,000
+151.1%
0.00%
Q3 2019$6,000
-70.0%
10,356
-49.0%
0.00%
Q2 2019$20,000
-47.4%
20,316
-25.1%
0.00%
Q1 2019$38,000
-50.6%
27,142
-61.9%
0.00%
Q4 2018$77,000
-95.7%
71,288
-75.4%
0.00%
Q3 2018$1,781,000
+367.5%
289,626
+712.5%
0.00%
Q2 2018$381,000
-75.2%
35,645
-75.1%
0.00%
Q1 2018$1,534,000
+4848.4%
142,941
+3104.2%
0.00%
Q4 2017$31,000
-3.1%
4,461
+28.5%
0.00%
Q2 2017$32,000
-82.0%
3,471
-84.5%
0.00%
Q1 2017$178,000
+270.8%
22,420
+706.5%
0.00%
Q3 2016$48,0002,7800.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,462,500$11,993,0006.16%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$6,410,0002.56%
AJU IB Investment Co., Ltd. 293,555$1,430,0000.82%
RTW INVESTMENTS, LP 4,206,765$20,487,0000.31%
Carmignac Gestion 3,419,877$16,655,0000.19%
EAM Investors, LLC 247,561$1,206,0000.19%
Curi Wealth Management, LLC 25,000$121,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,542,0000.03%
TWO SIGMA ADVISERS, LP 990,000$4,821,0000.01%
CAXTON ASSOCIATES LP 24,677$120,0000.01%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders